Literature DB >> 2446214

Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.

A J Stoessl1, C T Dourish, S C Young, B J Williams, S D Iversen, L L Iversen.   

Abstract

Behavioural responses to tachykinins were observed following intracisternal administration in mice. The synthetic NK-3 agonists senktide and L-363,851 caused behaviour typically associated with serotonergic stimulation, including head twitches, reciprocal forepaw treading and hindlimb splaying. Neurokinin B produced some features of the serotonin (5-HT) syndrome, while substance P, neurokinin A and eledoisin failed to elicit any such behaviours. Senktide-induced head twitches were prevented by pretreatment with the 5-HT2 antagonists ketanserin and ritanserin, while forepaw treading was attenuated by the 5-HT1 antagonists (-)-pindolol and methysergide. These data suggest that NK-3 agonists interact with central 5-HT mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446214     DOI: 10.1016/0304-3940(87)90475-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.

Authors:  Liliane J Dableh; Kiran Yashpal; Joseph Rochford; James L Henry
Journal:  Eur J Pharmacol       Date:  2004-12-28       Impact factor: 4.432

4.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.

Authors:  T Sakurada; H Yogo; Y Manome; K Tan-No; S Sakurada; A Yamada; K Kisara; M Ohba
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.